News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Montana State University, Montana BioScience Alliance
|
March 4, 2023

MSU will host a free one-day workshop for biotechnology entrepreneurs and others interested in business ventures involving the life-sciences. The event will present practical information about starting a company, securing intellectual property, fundraising and licensing technology. The event is co-sponsored by the Montana Bioscience Alliance and the Montana Innovation Partnership.

Awards will be offered by the National Institutes of Health and will be linked to grants currently held by the Institute of Translational Health Services and are open to: (1) students enrolled in doctoral programs at institutions of higher education in Washington, Wyoming, Alaska, Montana, and Idaho meeting T32/TL1 eligibility criteria, who can request 2 to 3 years of support for stipend and tuition, and (2) early career faculty and postdoctoral investigators meeting KL2 eligibility criteria, who can request support for 3 […]

Gaize, Inc. has announced the launch of their impairment screening solution for cannabis and other drugs. The product is a first-of-its-kind fully automated, non-invasive and portable eye movement test. It’s an objective way to detect the involuntary eye movement changes associated with impairment. Gaize recently completed the world’s largest cannabis impairment clinical trial, which validated the effectiveness of the product.

Alercell has launched a new website—Lena Diagnostics, www.lenadx.com—dedicated to proprietary tests focused on early detection of cancer and leukemia.

NIAID — Rocky Mountain Laboratories
|
February 7, 2023

A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.

ARTICLES OF INTEREST

National Institutes of Health
|
March 27, 2023

SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]

FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.

Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology  that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.

Doctors have told health services to prepare for a new era of cancer screening after a study found a simple blood test could spot multiple cancer types in patients before they develop clear symptoms.

It’s been 60 years since President Kennedy delivered his iconic moonshot speech, marking a goal for America to launch a man into space to step foot on the moon, and bring him back to Earth. On Sept. 12, President Biden gave a speech at the Kennedy Presidential Library in Boston, outlining the progress on his own self-described moonshot: ending cancer.

NEWSLETTER

Newsletter
|
February 2, 2023

View the Winter 2022 now!

Newsletter
|
November 30, 2022

View the Fall 2022 now!